Atypical Hemolytic-Uremic Syndrome (aHUS) Registry

Clinical trial NCT01522183 · RECRUITING

Trial details

NCT number: NCT01522183
Sponsor: Alexion Pharmaceuticals, Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Atypical Hemolytic-Uremic Syndrome

Start date: 2013-03-18
Primary completion: 2031-01-01
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.